Brandtree

Who owns Tafirol?

Tafirol is owned by Genomma Lab (Mexico, BMV: LAB), which has owned the brand since 2013.[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV), Genomma Lab Internacional, S.A.B. de C.V. Last checked .

Key facts

Current owner
Genomma Lab Internacional, S.A.B. de C.V. reported
Owned since
Owner HQ
🇲🇽 Mexico, Mexico City
Origin
🇦🇷 Argentina
Category
Consumer health › Over-the-counter medicine › Pain relief
Parent ticker
BMV: LAB
Last verified
· 1 sources

About Tafirol

Tafirol is a paracetamol painkiller and the outright leader of the Argentine analgesics market, with a 47 per cent share by units sold. Genomma Lab acquired it in 2013 through its Argentine subsidiary and it has grown steadily since, helped in 2020 when health authorities recommended paracetamol for the first symptoms of covid-19. It was 6.3 per cent of the company's sales in 2025.

Ownership timeline of Tafirol

Owners of Tafirol over 2013 to 2026 Genomma Lab 2013–present Genomma Lab 201320142015201620172018201920202021202220232024202520262027
  1. 2013 – present Genomma Lab [1] reported

Where Tafirol sits in Genomma Lab

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Tafirol sits in Genomma Lab Tree of 13 brands under Genomma Lab. Genomma Lab Tafirol Asepxia Bufferin (United States) Cicatricure Kaopectate Nikzon and 7 more

Open the full Genomma Lab ownership tree →

See the full Genomma Lab brand portfolio (13) →

Other brands owned by Genomma Lab

Genomma Lab controls 13 brands on Brandtree, 6 of them in consumer health.

Also in consumer health

All Genomma Lab brands →

Other brands in pain relief, and who owns them

The 37 brands in pain relief on Brandtree belong to 21 owners. The largest is Haleon, with 3; Genomma Lab has 2.

BrandOwnerOwner based in
Advil Haleon 🇬🇧 United Kingdom
Air Salonpas Hisamitsu Pharmaceutical 🇯🇵 Japan
Motrin Kenvue 🇺🇸 United States
Dafalgan Taisho Pharmaceutical 🇯🇵 Japan
Nicotex Cipla 🇮🇳 India
Mentho Plus Emami 🇮🇳 India
Doril Hypera 🇧🇷 Brazil
Daleron Krka 🇸🇮 Slovenia

Every brand in pain relief and its owner →

About the owner: Genomma Lab

Genomma Lab is a publicly listed company headquartered in Mexico City, Mexico, founded in 1996. Brandtree records 13 brands under its control, and it is listed as BMV: LAB.

Genomma Lab Internacional is a Mexican over-the-counter medicine and personal care company that began in 1996 as a direct-response advertiser making its own television infomercials, moved into developing products of its own from 1997, and floated on the Mexican stock exchange as LAB on 18 June 2008. It sells more than 50 active brands in Mexico and eighteen countries beyond it, and puts its share of the Mexican over-the-counter market at 5.9 per cent and of the personal care categories it competes in at 5.0 per cent. Much of the portfolio was bought rather than invented.

Genomma Lab: full profile, brands and acquisition history →

🇦🇷 Tafirol and other Argentine brands

Brandtree records a controlling owner for 117 brands that began in Argentina. 30 of them (26%) are now controlled by a company headquartered in another country, Tafirol among them.

All Argentine brands and who owns them →

Frequently asked questions

Who is the parent company of Tafirol?

The parent company of Tafirol is Genomma Lab, a publicly listed company headquartered in Mexico.

Is Tafirol Argentine or Mexican?

Tafirol originated in Argentina, but it is owned today by Genomma Lab, which is headquartered in Mexico. So Tafirol is an Argentine-origin brand under Mexican ownership.

Since when has Genomma Lab owned Tafirol?

Genomma Lab has owned Tafirol since 2013.

Is Tafirol still owned by Genomma Lab?

Yes. As of 23 September 2026, Tafirol is still owned by Genomma Lab. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Genomma Lab Internacional — Reporte Anual 2025 (Anexo N, BMV) — Genomma Lab Internacional, S.A.B. de C.V., Annual report; retrieved 23 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.